Literature DB >> 10669661

Determinants of population changes in fibrinogen and factor VII over 6 years: the Atherosclerosis Risk in Communities (ARIC) Study.

A R Folsom1, K K Wu, M Rasmussen, L E Chambless, N Aleksic, F J Nieto.   

Abstract

Although numerous cross-sectional studies have identified possible determinants of plasma fibrinogen and factor VII levels, few prospective studies exist. We assessed the longitudinal relation of changes in fibrinogen and factor VII over 6 years with changes to other cardiovascular risk factors in a sample of 440 men and 549 women from the Atherosclerosis Risk in Communities (ARIC) study. Fibrinogen increased more in older participants, those with or who developed diabetes, those who at any time smoked, and those whose plasma HDL cholesterol or triglycerides decreased and increased less in female participants who started hormonal replacement therapy. Factor VII coagulant activity increased more in younger participants, women, those who gained greater weight or developed diabetes, those who quit smoking, those in whom plasma triglycerides decreased, and female participants who received hormonal replacement therapy. Thus, our longitudinal data suggest with some exceptions that adverse changes in cardiovascular risk factors are accompanied by increases in plasma levels of fibrinogen and factor VII.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669661     DOI: 10.1161/01.atv.20.2.601

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  9 in total

1.  Long-term variability of inflammatory markers and associated factors in a population-based cohort.

Authors:  Scott D Nash; Karen J Cruickshanks; Ronald Klein; Barbara E K Klein; F Javier Nieto; Rick Chappell; Carla R Schubert; Michael Y Tsai
Journal:  J Am Geriatr Soc       Date:  2013-07-26       Impact factor: 5.562

2.  C-reactive protein and chitinase 3-like protein 1 as biomarkers of spatial redistribution of retinal blood vessels on digital retinal photography in patients with diabetic retinopathy.

Authors:  Sonja Cekić; Tatjana Cvetković; Ivan Jovanović; Predrag Jovanović; Milica Pesić; Gordana Stanković Babić; Svetislav Milenković; Dijana Risimić
Journal:  Bosn J Basic Med Sci       Date:  2014-08-20       Impact factor: 3.363

3.  Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA study.

Authors:  D Green; C Chan; J Kang; K Liu; P Schreiner; N S Jenny; R P Tracy
Journal:  J Thromb Haemost       Date:  2009-12-15       Impact factor: 5.824

Review 4.  Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics.

Authors:  Allison E Aiello; George A Kaplan
Journal:  Biodemography Soc Biol       Date:  2009

5.  [Effect on plasma fibrinogen of hypercholesterolaemia treatment with pravastatin].

Authors:  J Murciano Revert; J J Martínez-Lahuerta; L Aleixandre Porcar; M Debón Belda
Journal:  Aten Primaria       Date:  2001-04-15       Impact factor: 1.137

6.  Pleiotropic effects of n-6 and n-3 fatty acid-related genetic variants on circulating hemostatic variables.

Authors:  Lu-Chen Weng; Weihua Guan; Lyn M Steffen; James S Pankow; Nathan Pankratz; Ming-Huei Chen; Mary Cushman; Saonli Basu; Aaron R Folsom; Weihong Tang
Journal:  Thromb Res       Date:  2018-06-01       Impact factor: 3.944

7.  13-year long-term associations between changes in traditional cardiovascular risk factors and changes in fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  Tochi M Okwuosa; Oana Klein; Cheeling Chan; Nancy Swords Jenny; Pamela Schreiner; David Green; Kiang Liu
Journal:  Atherosclerosis       Date:  2012-10-25       Impact factor: 5.162

8.  Prediction of Lipoprotein-Associated Phospholipase A2 and Inflammatory Markers in Subclinical Atherosclerosis in Premature Ovarian Failure Patients.

Authors:  Yusuf Cekici; Salih Kilic; Ali Ovayolu; Erhan Saracoglu; İrfan Veysel Duzen; Mucahid Yilmaz; Bedri Caner Kaya; Devrim Bozkurt
Journal:  Acta Cardiol Sin       Date:  2021-01       Impact factor: 2.672

9.  Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS).

Authors:  S S Soedamah-Muthu; N Chaturvedi; J C Pickup; J H Fuller
Journal:  Diabetologia       Date:  2008-01-09       Impact factor: 10.122

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.